Finding the best prices at pharmacies near you...

Prescription & Medication Blog

At RxSpark we believe prescription drugs and medication should be accessible and affordable for all Americans. In addition to the savings, discounts, and convenience that RxSpark provides, the RxSpark Blog is here to bring you information, news, current events, and important upates on topics that affect healthcare and prescription drugs. Be sure to check back frequently for updates, and if you find any information that is particularly helpful please don't hesitate to share!



Adcetris approved as treatment for classical Hodgkin lymphoma

The US Food and Drug Administration (FDA) has approved Adcetris (brentuximab vedotin) as a treatment for certain adult patients with classical Hodgkin lymphoma (cHL). Under the latest approval, the Seattle Genetics drug is indicated for use in combination with chemotherapy as a treatment for...

Read More

Outpatient pharmacy costs ‘higher at 340B hospitals’

Annual per patient outpatient pharmacy costs at hospitals participating in the 340B Drug Discount Program are significantly higher than in non-340B hospitals, according to new analysis from the Pharmaceutical Research and Manufacturers of America (PhRMA). The analysis, prepared by Milliman and...

Read More

Trogarzo approved as treatment option for patients with MDR HIV

A new treatment option is available for patients with multi-drug resistant (MDR) HIV following the US Food and Drug Administration’s (FDA) approval of Trogarzo (ibalizumab-uiyk). The medication, developed by TaiMed Biologics USA Corp, is a new form of antiretroviral medication indicated for...

Read More

Benefits of universal flu vaccination highlighted in new study

Universal vaccination against the flu could help slow the spread of the disease in the future, according to a recent study into the efficacy of flu vaccines. The clinical trial conducted by GlaxoSmithKline (GSK) examined the efficacy of Fluarix Tetra (inactivated quadrivalent influenza vaccine...

Read More

Which New Generic Drugs will be in US Pharmacies in 2018?

Last year was a record-breaking year for generic drug approvals in the United States. The US Food and Drug Administration (FDA) approved 1,027 generic drugs, 843 of which were full approvals, with tentative approvals making up the remainder. Tentative approvals are generic drugs considered ready...

Read More

Antiviral drug Acyclovir recalled due to product mix-up

Apace Packaging LLC has issued a nationwide voluntary recall of one lot of the antiviral medication acyclovir due to a product mix-up. Acyclovir is a widely used medication prescribed to treat several infections, notably infections caused by the herpes virus, such as genital herpes, cold sores,...

Read More

FluMist: Nasal influenza vaccine to return for 2018-19 flu season

Nasal influenza vaccines could be set to make a return for the 2018-19 flu season after a vaccine advisory group for the Centers for Disease Control and Prevention (CDC) voted to include FluMist in the immunization options for the coming year.  FluMist provides a route of administration for...

Read More

CDC recommends new shingles vaccine Shingrix

The Centers for Disease Control and Prevention (CDC) now formally recommends Shingrix (zoster vaccine recombinant, adjuvanted) as the vaccine of choice against shingles. It is only the second shingles vaccine to gain US Food and Drug Administration approval; the first was Merck’s drug...

Read More

Opiod cough medicines labeling changed to exclude pediatric use

In the latest step taken by the US Food and Drug Administration (FDA) to address the nation's opioid abuse epidemic, the agency has changed the indication of cough medicines containing opioids to exclude all pediatric patients.  Following the latest safety labeling changes, opioid cough and...

Read More